REPORTING OF TRANSACTIONS IN ORPHAZYME'S SHARES MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Copenhagen, July 26, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announces that, pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme:

1 Details of the Reporting Person / Closely Associated Person

a) Name

Thomas Blaettler

2 Reason for the notification

a) Position/status

Chief Medical Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Purchase of shares

c) Price(s) and volume(s)

Price (s)

Volume(s)

DKK 63.00

1,011

DKK 63.00

2,022

DKK 63.00

1,342

d) Aggregated information

- Aggregated volume

- Price

Aggregated volume: 4,375

Price: DKK 63.00

e) Date of the transaction

July 25, 2019 07:00 UTC-time

f) Place of the transaction

Nasdaq Copenhagen A/S - XCSE

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Thomas Kirkegaard Jensen

2 Reason for the notification

a) Position/status

Chief Scientific Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Purchase of shares

c) Price(s) and volume(s)

Price (s)

Volume(s)

DKK 62.40

47

DKK 62.80

500

DKK 62.80

253

DKK 62.60

411

DKK 62.80

500

DKK 62.80

539

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume: 2,250

Price: DKK 62.76

e) Date of the transaction

July 26, 2019 between 10:11 and 10:14 UTC-time

f) Place of the transaction

Nasdaq Copenhagen A/S - XCSE